| Cyclosporine before PCI in patients with acute myocardial infarction TT Cung, O Morel, G Cayla, G Rioufol, D Garcia-Dorado, D Angoulvant, ... New England Journal of Medicine 373 (11), 1021-1031, 2015 | 798 | 2015 |
| Cellular mechanisms underlying the formation of circulating microparticles O Morel, L Jesel, JM Freyssinet, F Toti Arteriosclerosis, thrombosis, and vascular biology 31 (1), 15-26, 2011 | 683 | 2011 |
| Procoagulant microparticles: disrupting the vascular homeostasis equation? O Morel, F Toti, B Hugel, B Bakouboula, L Camoin-Jau, F Dignat-George, ... Arteriosclerosis, thrombosis, and vascular biology 26 (12), 2594-2604, 2006 | 635 | 2006 |
| Cardiovascular effects of air pollution T Bourdrel, MA Bind, Y Béjot, O Morel, JF Argacha Archives of cardiovascular diseases 110 (11), 634-642, 2017 | 552 | 2017 |
| Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary … D Aradi, A Kirtane, L Bonello, PA Gurbel, US Tantry, K Huber, ... European heart journal 36 (27), 1762-1771, 2015 | 428 | 2015 |
| Cellular microparticles: a disseminated storage pool of bioactive vascular effectors O Morel, F Toti, B Hugel, JM Freyssinet Current opinion in hematology 11 (3), 156-164, 2004 | 413 | 2004 |
| Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non–ST-elevation acute coronary syndrome: results of the multicenter … N Meneveau, G Souteyrand, P Motreff, C Caussin, N Amabile, P Ohlmann, ... Circulation 134 (13), 906-917, 2016 | 351 | 2016 |
| Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression S Martin, A Tesse, B Hugel, MC Martínez, O Morel, JM Freyssinet, ... Circulation 109 (13), 1653-1659, 2004 | 325 | 2004 |
| Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) N Bouabdallaoui, JC Tardif, DD Waters, FJ Pinto, AP Maggioni, R Diaz, ... European heart journal 41 (42), 4092-4099, 2020 | 295 | 2020 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 293 | 2019 |
| Diagnostic and prognostic value of circulating D-dimers in patients with acute aortic dissection P Ohlmann, A Faure, O Morel, H Petit, H Kabbaj, N Meyer, E Cheneau, ... Critical care medicine 34 (5), 1358-1364, 2006 | 254 | 2006 |
| Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review AR Lyon, R Citro, B Schneider, O Morel, JR Ghadri, C Templin, ... Journal of the American College of Cardiology 77 (7), 902-921, 2021 | 253 | 2021 |
| Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years B Iung, X Armoiry, A Vahanian, F Boutitie, N Mewton, JN Trochu, ... European journal of heart failure 21 (12), 1619-1627, 2019 | 244 | 2019 |
| Comorbidities frequency in Takotsubo syndrome: an international collaborative systematic review including 1109 patients F Pelliccia, G Parodi, C Greco, D Antoniucci, R Brenner, E Bossone, ... The American journal of medicine 128 (6), 654. e11-654. e19, 2015 | 226 | 2015 |
| Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension B Bakouboula, O Morel, A Faure, F Zobairi, L Jesel, A Trinh, M Zupan, ... American journal of respiratory and critical care medicine 177 (5), 536-543, 2008 | 221 | 2008 |
| Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 212 | 2019 |
| Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses O Morel, N Morel, JM Freyssinet, F Toti Platelets 19 (1), 9-23, 2008 | 192 | 2008 |
| Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis O Morel, N Morel, L Jesel, JM Freyssinet, F Toti Seminars in immunopathology 33, 469-486, 2011 | 177 | 2011 |
| Von Willebrand factor multimers during transcatheter aortic-valve replacement E Van Belle, A Rauch, F Vincent, E Robin, M Kibler, J Labreuche, ... New England Journal of Medicine 375 (4), 335-344, 2016 | 170 | 2016 |
| Generation of procoagulant microparticles in cerebrospinal fluid and peripheral blood after traumatic brain injury N Morel, O Morel, L Petit, B Hugel, JF Cochard, JM Freyssinet, F Sztark, ... Journal of Trauma and Acute Care Surgery 64 (3), 698-704, 2008 | 160 | 2008 |
